We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Resmed Inc
13 own
3 watching
Current Price
$136.61
$0.32
(0.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
20,143.83M
52-Week High
242.42
52-Week Low
136.22
Average Volume
1.52M
Dividend Yield
0.006102
P/E Ratio
76.5676
Market Capitalization20,143.83M52-Week High242.4252-Week Low136.22Average Volume1.52MDividend Yield0.006102P/E Ratio76.5676What does the Resmed Inc do?
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More
How much money does Resmed Inc make?
News & Events about Resmed Inc.
Zolmax
3 months ago
ResMed Inc. (NYSE:RMD Get Rating) insider David Pendarvis sold 1,500 shares of ResMed stock in a transaction on Monday, June 5th. The stock was sold at an average price of $219.79, for a total transaction of $329,685.00. Following the transaction, the insider now directly owns 89,729 shares of the ...
Ticker Report
5 months ago
ResMed Inc. (NYSE:RMD Get Rating) COO Robert Andrew Douglas sold 1,500 shares of ResMed stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $224.65, for a total transaction of $336,975.00. Following the completion of the sale, the chief ...
Zolmax
6 months ago
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 shares ...
Ticker Report
6 months ago
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 ...
Frequently Asked Questions
Frequently Asked Questions
What is Resmed Inc share price today?
Can Indians buy Resmed Inc shares?
How can I buy Resmed Inc shares from India?
Can Fractional shares of Resmed Inc be purchased?
What are the documents required to start investing in Resmed Inc stocks?
What is today’s traded volume of Resmed Inc?
What is today’s market capitalisation of Resmed Inc?
What is the 52-Week High and Low Range of Resmed Inc?
What percentage is Resmed Inc down from its 52-Week High?
What percentage is Resmed Inc up from its 52-Week Low?
Current Price
$136.61
$0.32
(0.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.